RCE recce pharmaceuticals ltd

Ann: Positive Phase II Data from Clinical Trial of R327 Gel, page-20

  1. 910 Posts.
    lightbulb Created with Sketch. 436
    Here is the trial registration efficacy outcome:

    To evaluate the efficacy of RECCE®327 topical gel on ABSSSI
    Assessment method: Wound swab samples to evaluate for bacterial culture.
    Timepoint: Wound swabs will be taken at the following timepoints: - Day 1 (baseline), - Day 7 - Day 14


    Where is this data? They haven't mentioned cultures or swabs at all. They are suddenly talking about Lipsky and Bates as evidence for meeting their outcomes. Why are they moving the goalposts?

    Further, the primary outcome is about bioavailability. Where is this data? Are you really accepting a vague statement about having "met" this endpoint? Was there systemic absorbtion? Is that important? How much? Does it depend on wound type?

    As always with Recce, it's what they are not saying that actually tells you all you need to know.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
38.8¢
Change
0.003(0.65%)
Mkt cap ! $112.0M
Open High Low Value Volume
38.5¢ 39.0¢ 38.0¢ $4.167K 10.76K

Buyers (Bids)

No. Vol. Price($)
2 24610 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 49817 1
View Market Depth
Last trade - 15.44pm 31/07/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.